Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sahdev

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Endocrinology, Diabetes & Metabolism Case Reports|August 15, 2015
Pure aldosterone-secreting adrenocortical carcinoma in a patient with refractory primary hyperaldosteronismS Hussain, E Panteliou, D M Berney, et al.
Clinical Radiology|February 16, 2005
The role of magnetic resonance imaging and ultrasound in patients with adnexal massesS A Sohaib, T D Mills, A Sahdev, et al.
British Journal of Cancer|December 25, 2013
Diffusion-weighted and multiphase contrast-enhanced MRI as surrogate markers of response to neoadjuvant sunitinib in metastatic renal cell carcinomaN Bharwani, M E Miquel, T Powles, et al.
QJM : Monthly Journal of the Association of Physicians|February 10, 2017
Clinical outcomes following unilateral adrenalectomy in patients with primary aldosteronismM J Hannon, W C Sze, R Carpenter, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 13, 2007
Differential diagnosis of adnexal masses: risk of malignancy index, ultrasonography, magnetic resonance imaging, and radioimmunoscintigraphyP O van Trappen, B D Rufford, T D Mills, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2013
A prospective evaluation of VEGF-targeted treatment cessation in metastatic clear cell renal cancerT Powles, I Kayani, K Sharpe, et al.
Clinical Radiology|July 6, 2013
Prostate MRI: who, when, and how? Report from a UK consensus meetingA P S Kirkham, P Haslam, J Y Keanie, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Endocrinology, Diabetes & Metabolism Case Reports|August 15, 2015
Pure aldosterone-secreting adrenocortical carcinoma in a patient with refractory primary hyperaldosteronismS Hussain, E Panteliou, D M Berney, et al.
Clinical Radiology|February 16, 2005
The role of magnetic resonance imaging and ultrasound in patients with adnexal massesS A Sohaib, T D Mills, A Sahdev, et al.
British Journal of Cancer|December 25, 2013
Diffusion-weighted and multiphase contrast-enhanced MRI as surrogate markers of response to neoadjuvant sunitinib in metastatic renal cell carcinomaN Bharwani, M E Miquel, T Powles, et al.
QJM : Monthly Journal of the Association of Physicians|February 10, 2017
Clinical outcomes following unilateral adrenalectomy in patients with primary aldosteronismM J Hannon, W C Sze, R Carpenter, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 13, 2007
Differential diagnosis of adnexal masses: risk of malignancy index, ultrasonography, magnetic resonance imaging, and radioimmunoscintigraphyP O van Trappen, B D Rufford, T D Mills, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2013
A prospective evaluation of VEGF-targeted treatment cessation in metastatic clear cell renal cancerT Powles, I Kayani, K Sharpe, et al.
Clinical Radiology|July 6, 2013
Prostate MRI: who, when, and how? Report from a UK consensus meetingA P S Kirkham, P Haslam, J Y Keanie, et al.
Pageof 3